Schonfeld Strategic Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-228,474
| Closed | -$5.52M | – | 2414 |
|
|
2025
Q1 | $5.52M | Buy |
+228,474
| New | +$5.52M | 0.03% | 437 |
|
|
2024
Q4 | – | Sell |
-51,109
| Closed | -$3.24M | – | 2260 |
|
|
2024
Q3 | $3.24M | Buy |
51,109
+22,467
| +78% | +$1.42M | 0.02% | 585 |
|
|
2024
Q2 | $1.52M | Sell |
28,642
-5,007
| -15% | -$265K | 0.01% | 909 |
|
|
2024
Q1 | $2.76M | Buy |
+33,649
| New | +$2.76M | 0.02% | 731 |
|
|
2023
Q4 | – | Sell |
-53,900
| Closed | -$597K | – | 2088 |
|
|
2023
Q3 | $597K | Buy |
53,900
+7,947
| +17% | +$88K | ﹤0.01% | 1038 |
|
|
2023
Q2 | $745K | Sell |
45,953
-284,402
| -86% | -$4.61M | 0.01% | 1060 |
|
|
2023
Q1 | $5.5M | Buy |
330,355
+195,211
| +144% | +$3.25M | 0.05% | 417 |
|
|
2022
Q4 | $1.27M | Buy |
135,144
+56,924
| +73% | +$535K | 0.01% | 1026 |
|
|
2022
Q3 | $213K | Sell |
78,220
-9,500
| -11% | -$25.9K | ﹤0.01% | 2248 |
|
|
2022
Q2 | $254K | Buy |
+87,720
| New | +$254K | ﹤0.01% | 1683 |
|
|
2019
Q3 | – | Sell |
-475,400
| Closed | -$3.95M | – | 1243 |
|
|
2019
Q2 | $3.95M | Sell |
475,400
-178,900
| -27% | -$1.48M | 0.14% | 179 |
|
|
2019
Q1 | $6.5M | Buy |
+654,300
| New | +$6.5M | 0.23% | 120 |
|